Actively Recruiting
Reducing Frailty for Older Cancer Survivors Using Supplements II
Led by University of Rochester · Updated on 2026-03-06
118
Participants Needed
1
Research Sites
322 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study is a two-arm placebo controlled randomized clinical trial, to assess the effect of a 12-week EGCG intervention on physical frailty compared to placebo in pre-frail older cancer survivors.
CONDITIONS
Official Title
Reducing Frailty for Older Cancer Survivors Using Supplements II
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Be age 65 or over.
- Be diagnosed with stage I-III cancer.
- Have completed curative intent treatment 10 years or less before screening.
- Patients on Anastrozole, Leuprolide acetate, or Bicalutamide endocrine therapies are allowed.
- Have a Fried's Frailty Score of 1 or greater.
- Able to provide informed consent.
You will not qualify if you...
- Have chemotherapy or other systemic cancer treatment planned during the study period.
- Have abnormal liver function tests (ALT or AST over 3 times upper limit, bilirubin over 1.5 times upper limit) within 3 months.
- Have uncontrolled or unmanaged liver disease.
- Consume more than 6 cups of green tea per day.
- Have known allergies to caffeine.
- Have a major psychiatric illness requiring hospitalization within the last year.
- Have been diagnosed with dementia.
- Cannot provide informed consent due to lack of decision-making capacity as determined by the oncologist.
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
University of Rochester
Rochester, New York, United States, 14627
Actively Recruiting
How is the study designed?
Study Type
INTERVENTIONAL
Masking
TRIPLE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here